In VitroActivity of the New Fluoroketolide Solithromycin (CEM-101) against Macrolide-Resistant and -Susceptible Mycoplasma genitalium Strains
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In VitroActivity of the New Fluoroketolide Solithromycin (CEM-101) against Macrolide-Resistant and -Susceptible Mycoplasma genitalium Strains
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 58, Issue 6, Pages 3151-3156
Publisher
American Society for Microbiology
Online
2014-03-18
DOI
10.1128/aac.02411-14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial Pneumonia
- (2013) David Oldach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance
- (2013) Deborah L Couldwell et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Treatment of Mycoplasma genitalium. Observations from a Swedish STD Clinic
- (2013) Carin Anagrius et al. PLoS One
- O02.4 Persistent/Recurrent Chlamydial Infection Among STD Clinic Patients Treated with CDC-Recommended Therapies
- (2013) C M Khosropour et al. SEXUALLY TRANSMITTED INFECTIONS
- In VitroActivity of the New Fluoroketolide Solithromycin (CEM-101) against a Large Collection of Clinical Neisseria gonorrhoeae Isolates and International Reference Strains, Including Those with High-Level Antimicrobial Resistance: Potential Treatment Option for Gonorrhea?
- (2012) Daniel Golparian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Standard Treatment Regimens for Nongonococcal Urethritis Have Similar but Declining Cure Rates: A Randomized Controlled Trial
- (2012) Lisa E. Manhart, Catherine W. Gillespie, M. Sylvan Lowens, Christine M. Khosropour, Danny V. Colombara, Matthew R. Golden, Navneet R. Hakhu, Katherine K. Thomas, James P. Hughes, Nicole L. Jensen, Patricia A. Totten CLINICAL INFECTIOUS DISEASES
- Investigating the entire course of telithromycin binding to Escherichia coli ribosomes
- (2012) Ourania N. Kostopoulou et al. NUCLEIC ACIDS RESEARCH
- Pharmacokinetics of Solithromycin (CEM-101) after Single or Multiple Oral Doses and Effects of Food on Single-Dose Bioavailability in Healthy Adult Subjects
- (2011) J. Gordon Still et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mycoplasma genitalium: from Chrysalis to Multicolored Butterfly
- (2011) D. Taylor-Robinson et al. CLINICAL MICROBIOLOGY REVIEWS
- Binding and Action of CEM-101, a New Fluoroketolide Antibiotic That Inhibits Protein Synthesis
- (2010) B. Llano-Sotelo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- IsMycoplasma genitaliumin Women the “New Chlamydia?” A Community‐Based Prospective Cohort Study
- (2010) Pippa Oakeshott et al. CLINICAL INFECTIOUS DISEASES
- Re-Evaluating the Treatment of Nongonococcal Urethritis: Emphasizing Emerging Pathogens-A Randomized Clinical Trial
- (2010) J. R. Schwebke et al. CLINICAL INFECTIOUS DISEASES
- Genetic Variation in the Complete MgPa Operon and Its Repetitive Chromosomal Elements in Clinical Strains of Mycoplasma genitalium
- (2010) Liang Ma et al. PLoS One
- In Vitro Activity of CEM-101, a New Fluoroketolide Antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae
- (2009) P. M. Roblin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Susceptibilities of Mycoplasma genitalium Strains Examined by Broth Dilution and Quantitative PCR
- (2009) R. Hamasuna et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Susceptibilities of Human Mycoplasmas and Ureaplasmas to a New Investigational Ketolide, CEM-101
- (2009) K. B. Waites et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cellular Accumulation and Pharmacodynamic Evaluation of the Intracellular Activity of CEM-101, a Novel Fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in Human THP-1 Macrophages
- (2009) S. Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with Defined Macrolide Resistance Mechanisms
- (2009) P. McGhee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Single‐Dose Azithromycin Treatment forMycoplasma genitalium–Positive Urethritis: Best but Not Good Enough
- (2009) Jørgen Skov Jensen CLINICAL INFECTIOUS DISEASES
- Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system
- (2008) Liang Ma et al. BMC MICROBIOLOGY
- Azithromycin Treatment Failure inMycoplasma genitalium–Positive Patients with Nongonococcal Urethritis Is Associated with Induced Macrolide Resistance
- (2008) Jørgen S. Jensen et al. CLINICAL INFECTIOUS DISEASES
- Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study
- (2008) E Jernberg et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Persistence of Mycoplasma genitalium Following Azithromycin Therapy
- (2008) Catriona S. Bradshaw et al. PLoS One
- Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial
- (2007) E Bjornelius et al. SEXUALLY TRANSMITTED INFECTIONS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started